ENDOMETRIAL CANCER STAGE I

This adverse event was reported 167 times

These drugs are most commonly taken by patients reporting ENDOMETRIAL CANCER STAGE I:

# Drug Count
0 METFORMIN 15
1 METFORMIN ER 500 MG 15
2 METFORMIN ER 750 MG 15
3 METOPROLOL 15
4 METOPROLOL TARTRATE 15
5 ASPIRIN 14
6 ASPIRIN 325 MG 14
7 ASPIRIN 81 MG 14
8 HYDROCHLOROTHIAZIDE 14
9 METOPROLOL TARTRATE INJECTION 14
See all common drugs associated with ENDOMETRIAL CANCER STAGE I

ENDOMETRIAL CANCER STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ESTRONE 2 0.0187
1 DROSPIRENONE AND ESTRADIOL 1 0.0019
2 CONJUGATED ESTROGENS/BAZEDOXIFENE 1 0.0011
3 DEXTROMETHORPHAN HBR, GUAIFENESIN 1 0.0010
4 LEVONORGESTREL/ETHINYL ESTRADIOL 1 0.0009
5 MITOMYCIN 2 0.0005
6 TAMOXIFEN CITRATE 3 0.0005
7 DOSTARLIMAB 1 0.0004
8 OCTREOTIDE ACETATE 12 0.0004
9 DIMENHYDRINATE 4 0.0004
See all drugs enriched for association with ENDOMETRIAL CANCER STAGE I

ENDOMETRIAL CANCER STAGE I is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Monobactam Antibacterial [EPC] 2 0.0007
1 Progesterone [EPC] 7 0.0003
2 Sulfone [EPC] 2 0.0002
3 Provitamin D2 Compound [EPC] 5 0.0002
4 Vitamin K [EPC] 1 0.0001
5 Estrogen [EPC] 19 0.0001
6 Interleukin-23 Antagonist [EPC] 9 0.0001
7 Thiazide Diuretic [EPC] 14 0.0001
8 Interferon beta [EPC] 10 0.0001
9 P2Y12 Platelet Inhibitor [EPC] 6 0.0001
See all drug classes enriched for association with ENDOMETRIAL CANCER STAGE I